T cell

Results: 2811



#Item
1PROTEIN QUANTITATION FROM WHOLE BLOOD ON POLYESTER-TONER LASER-PRINTED MICROFLUIDIC DISCS WITH CELL PHONE IMAGE ANALYSIS Brandon L. Thompson1, Yiwen Ouyang1,5, Jingyi Li1, Shannon T. Krauss1, Nishant Shukla2, Bryan G. Ke

PROTEIN QUANTITATION FROM WHOLE BLOOD ON POLYESTER-TONER LASER-PRINTED MICROFLUIDIC DISCS WITH CELL PHONE IMAGE ANALYSIS Brandon L. Thompson1, Yiwen Ouyang1,5, Jingyi Li1, Shannon T. Krauss1, Nishant Shukla2, Bryan G. Ke

Add to Reading List

Source URL: shukla.io

Language: English - Date: 2017-05-18 12:57:06
2Knots, three-manifolds and instantons P. B. Kronheimer and T. S. Mrowka Low-dimensional topology is the study of manifolds and cell complexes in dimensions four and below. Input from geometry and analysis has been centra

Knots, three-manifolds and instantons P. B. Kronheimer and T. S. Mrowka Low-dimensional topology is the study of manifolds and cell complexes in dimensions four and below. Input from geometry and analysis has been centra

Add to Reading List

Source URL: eta.impa.br

Language: English - Date: 2018-07-28 17:09:48
3IMPC phenotyping SOPs in JMC Immunophenotyping IMPC_IMM_001 Purpose This test differentiates immune cell sub-populations via flow cytometry. Description: increased CD4-positive T cell number (MP:), decreased CD4-p

IMPC phenotyping SOPs in JMC Immunophenotyping IMPC_IMM_001 Purpose This test differentiates immune cell sub-populations via flow cytometry. Description: increased CD4-positive T cell number (MP:), decreased CD4-p

Add to Reading List

Source URL: ja.brc.riken.jp

Language: English - Date: 2014-12-04 21:01:00
    4Articles  Asynchronous combinatorial action of four regulatory factors activates Bcl11b for T cell commitment  npg

    Articles Asynchronous combinatorial action of four regulatory factors activates Bcl11b for T cell commitment npg

    Add to Reading List

    Source URL: elowitz.caltech.edu

    Language: English - Date: 2016-10-13 17:44:50
      5

      Research Associate in HIV Vaccinology funded by the Gates Foundation T cell inducing vaccine for HIV ref. W1/MCEID

      Add to Reading List

      Source URL: www.europrise.org

      Language: English - Date: 2016-06-27 11:41:48
        6Potent and selective C-C chemokine receptor 4 (CCR4) antagonists inhibit regulatory T cell recruitment, increase effector T cell numbers, and potentiate anti-tumor responses in mice Oezcan Talay, Lisa Marshall, Cesar Mel

        Potent and selective C-C chemokine receptor 4 (CCR4) antagonists inhibit regulatory T cell recruitment, increase effector T cell numbers, and potentiate anti-tumor responses in mice Oezcan Talay, Lisa Marshall, Cesar Mel

        Add to Reading List

        Source URL: www.flxbio.com

        Language: English - Date: 2017-12-15 00:07:48
          7RIKEN QBiC Organization Chart (May1, 2017)  	 Cell Dynamics Research Core (T. Yanagida) Advisory Council Laboratory for Cell Dynamics Observation (T. Yanagida) Laboratory for Single Cell Gene Dynamics (Y. Taniguchi)

          RIKEN QBiC Organization Chart (May1, 2017)   Cell Dynamics Research Core (T. Yanagida) Advisory Council Laboratory for Cell Dynamics Observation (T. Yanagida) Laboratory for Single Cell Gene Dynamics (Y. Taniguchi)

          Add to Reading List

          Source URL: www.qbic.riken.jp

          Language: English - Date: 2017-05-29 05:27:35
            8Crescendo Biologics to attend 36th Annual J.P. Morgan Healthcare Conference 2018, San Francisco Cambridge, UK, 2 January 2018 – Crescendo Biologics Limited (Crescendo), the drug developer of novel, targeted T-cell enga

            Crescendo Biologics to attend 36th Annual J.P. Morgan Healthcare Conference 2018, San Francisco Cambridge, UK, 2 January 2018 – Crescendo Biologics Limited (Crescendo), the drug developer of novel, targeted T-cell enga

            Add to Reading List

            Source URL: www.crescendobiologics.com

            Language: English - Date: 2018-01-02 07:03:43
              9Crescendo Biologics to attend 12th Annual BIO-Europe Spring, 12-14 March 2018, Amsterdam Cambridge, UK, 9 March 2018 – Crescendo Biologics Limited (Crescendo), the drug developer of novel, targeted T-cell engaging ther

              Crescendo Biologics to attend 12th Annual BIO-Europe Spring, 12-14 March 2018, Amsterdam Cambridge, UK, 9 March 2018 – Crescendo Biologics Limited (Crescendo), the drug developer of novel, targeted T-cell engaging ther

              Add to Reading List

              Source URL: www.crescendobiologics.com

              Language: English - Date: 2018-03-09 04:08:41
                10

                VIRUSES PACKING AND CELL INFECTION Reagents OPTIMEM. HEK 293 T cells.

                Add to Reading List

                Source URL: www2.iib.uam.es

                Language: English - Date: 2011-08-11 10:47:03